◀ Back to GSK3B

GSK3B — VEGFA

Text-mined interactions from Literome

Guo et al., Stroke 2009 : In contrast, neither inhibition of GSK-3beta nor inhibition of PI3-K had any detectable effects on VEGF levels in astrocytes
Steindl-Kuscher et al., Invest Ophthalmol Vis Sci 2009 : VEGF , on the other hand, led to a reduction in cyclin D1 and to an increase in GSK 3beta and beta-catenin expression which was paralleled by an increase in RPE-specific differentiation markers
Maes et al., EMBO J 2010 : Genetic and pharmacological interventions showed that VEGF increased bone mass through a VEGF receptor 2- and phosphatidyl inositol 3-kinase mediated pathway inducing beta-catenin transcriptional activity in endothelial and osteoblastic cells, likely through modulation of glycogen synthase kinase 3-beta phosphorylation
Yang et al., Invest Ophthalmol Vis Sci 2010 : PEDF blocked VEGF induced phosphorylation of extracellular signal regulated kinase ( ERK ), p38 MAP kinase, the p38 substrate MAP kinase activated protein kinase-2 ( MAPKAPK-2 ), and GSK3-beta , but it had no effect on the phosphorylation of VEGFR2